O'Callaghan ME - Search Results

1

Survival outcomes in men with a positive family history of prostate cancer: a registry based study.

Ang M, Borg M, O'Callaghan ME; South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC). Ang M, et al. BMC Cancer. 2020 Sep 18;20(1):894. doi: 10.1186/s12885-020-07174-9. BMC Cancer. 2020. PMID: 32948129 Free PMC article.

2

Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.

Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Zalcberg J, Millar J, Evans S. Ruseckaite R, et al. BMC Res Notes. 2016 Jan 22;9:37. doi: 10.1186/s13104-016-1855-3. BMC Res Notes. 2016. PMID: 26801762 Free PMC article.

3

Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.

Ang M, Rajcic B, Foreman D, Moretti K, O'Callaghan ME. Ang M, et al. BJU Int. 2016 Apr;117 Suppl 4:68-75. doi: 10.1111/bju.13411. Epub 2016 Feb 18. BJU Int. 2016. PMID: 26890320

4

Prostate cancer in men aged less than 50 years at diagnosis.

Kinnear NJ, Kichenadasse G, Plagakis S, O'Callaghan ME, Kopsaftis T, Walsh S, Foreman D. Kinnear NJ, et al. World J Urol. 2016 Nov;34(11):1533-1539. doi: 10.1007/s00345-016-1824-4. Epub 2016 Apr 12. World J Urol. 2016. PMID: 27072535

5

Prostate cancer outcomes for men who present with symptoms at diagnosis.

Beckmann KR, O'Callaghan ME, Ruseckaite R, Kinnear N, Miller C, Evans S, Roder DM, Moretti K; South Australian Prostate Cancer Clinical Outcomes Collaborative. Beckmann KR, et al. BJU Int. 2017 Jun;119(6):862-871. doi: 10.1111/bju.13622. Epub 2016 Sep 3. BJU Int. 2017. PMID: 27489140

6

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.

Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Millar J, Evans S. Ruseckaite R, et al. BMC Cancer. 2016 Aug 5;16:607. doi: 10.1186/s12885-016-2655-9. BMC Cancer. 2016. PMID: 27496055 Free PMC article.

7

Prostate cancer outcomes and delays in care.

O'Callaghan ME, Shi Z, Kopsaftis T, Moretti K. O'Callaghan ME, et al. Int Urol Nephrol. 2017 Mar;49(3):449-455. doi: 10.1007/s11255-017-1508-z. Epub 2017 Jan 12. Int Urol Nephrol. 2017. PMID: 28083860

8

An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review.

Raymond E, O'Callaghan ME, Campbell J, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K. Raymond E, et al. Radiat Oncol. 2017 Mar 21;12(1):56. doi: 10.1186/s13014-017-0786-z. Radiat Oncol. 2017. PMID: 28327203 Free PMC article. Review.

9

Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.

O'Callaghan ME, Raymond E, Campbell JM, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K. O'Callaghan ME, et al. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):318-337. doi: 10.1016/j.ijrobp.2017.02.024. Epub 2017 Feb 21. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463151 Review.

10

Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy.

Beckmann K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K. Beckmann K, et al. ANZ J Surg. 2018 Mar;88(3):E183-E188. doi: 10.1111/ans.13954. Epub 2017 May 4. ANZ J Surg. 2018. PMID: 28471003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page